rAs to the value creation... this deal is a life saver for TherapeuticsMD, helping them to eliminate all debt, giving them ongoing loyalty and milestone payment and boosted their share price by 30%. but not sure for Mayne shareholders so far.
The products maybe ok but it's obviously not big sellers, the numbers can be searched from the reports available to public.
I agree it's too early to deny this drugs but such a rushed deal is questionable, market already responded with a 20 cents sp.
Have more Metrics proceeding to return to shareholders, Share buy backs... there are at least a few other "conservatives" options except this quick, un-proven deal with TherapeuticsMD.
rAs to the value creation... this deal is a life saver for...
-
- There are more pages in this discussion • 139 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.61 |
Change
-0.040(0.86%) |
Mkt cap ! $392.1M | |||
| Open | High | Low | Value | Volume |
| $4.66 | $4.70 | $4.57 | $498.0K | 107.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4333 | $4.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.64 | 126 | 1 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| MYX (ASX) Chart |